Advertisement
Research Article| Volume 117, ISSUE 5, P498-504, May 1995

Download started.

Ok

Mesocaval shunt or repeated sclerotherapy: Effects on rebleeding and encephalopathy — A randomized trial

  • Björn Isaksson
    Affiliations
    Department of Surgery Lund University Hospital, Lund, Sweden

    Department of Clinical Pharmacology, Lund University Hospital, Lund, Sweden

    Department of Roentgenology, Lund University Hospital, Lund, Sweden
    Search for articles by this author
  • Bengt Jeppsson
    Correspondence
    Reprint requests: Bengt Jeppsson, MD, PhD, Department of Surgery, Lund University Hospital, S-221 85 Lund, Sweden.
    Affiliations
    Department of Surgery Lund University Hospital, Lund, Sweden

    Department of Clinical Pharmacology, Lund University Hospital, Lund, Sweden

    Department of Roentgenology, Lund University Hospital, Lund, Sweden
    Search for articles by this author
  • Finn Bengtsson
    Affiliations
    Department of Surgery Lund University Hospital, Lund, Sweden

    Department of Clinical Pharmacology, Lund University Hospital, Lund, Sweden

    Department of Roentgenology, Lund University Hospital, Lund, Sweden
    Search for articles by this author
  • Peter Hannesson
    Affiliations
    Department of Surgery Lund University Hospital, Lund, Sweden

    Department of Clinical Pharmacology, Lund University Hospital, Lund, Sweden

    Department of Roentgenology, Lund University Hospital, Lund, Sweden
    Search for articles by this author
  • Per Herlin
    Affiliations
    Department of Surgery Lund University Hospital, Lund, Sweden

    Department of Clinical Pharmacology, Lund University Hospital, Lund, Sweden

    Department of Roentgenology, Lund University Hospital, Lund, Sweden
    Search for articles by this author
  • Stig Bengmark
    Affiliations
    Department of Surgery Lund University Hospital, Lund, Sweden

    Department of Clinical Pharmacology, Lund University Hospital, Lund, Sweden

    Department of Roentgenology, Lund University Hospital, Lund, Sweden
    Search for articles by this author
      This paper is only available as a PDF. To read, Please Download here.
      Background. Sclerotherapy is usually effective in controling acutely bleeding esophageal varices. It may not be as effective as shunt surgery for prevention of rebleeding; therefore we undertook a prospective study comparing interposition mesocaval shunt (MSC) and repeated sclerotherapy.
      Methods. Forty-five patients (mean age, 52.6±9.8 years) with variceal bleeding were randomized after emergency endoscopic sclerotherapy either to repeat variceal obliteration followed by regular check endoscopy (n=21) or to elective interposition mesocaval shunting by use of 14 mm polytetrafluoroethylene graft (n=24). There was an equal distribution of Child's classes in the two groups.
      Results. In the sclerotherapy group 12 patients had recurrent hemorrhages causing five deaths compared with the shunt group, in which four patients had postoperative bleeding but without associated death. No difference was noted in the incidence of encephalopathy despite the development of total shunting 1 year after MCS. The median hospital stay was similar; 34.5 days (MCS) and 33 days (sclerotherapy). The number of intensive care unit days was also similar in the two groups. No difference was noted in survival in patients with Child's A and Child's B disease in the treatment groups. In patients with Child's C cirrhosis there was a statistically significant longer survival in patients underoing MCS compared with patients undergoing sclerotherapy.
      Conclusions. The results of the study show that the rate of rebleeding is significantly higher after sclerotherapy than after mesocaval shunting. In patients with Child's C cirrhosis MCS may be an alternative to sclerotherapy for the prevention of rebleeding from esophageal varices in patients not suitable for transplantation.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Surgery
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Crafoord C
        • Frenckner P
        New surgical treatment of varicose veins of the esophagus.
        Acta Otolaryngol (Stockh). 1939; 27: 422-429
        • Westaby D
        • Hayes PC
        • Gimson AES
        • Polson RJ
        • Williams R
        Controlled clinical trial of injection sclerotherapy for active variceal bleeding.
        Hepatology. 1989; 9: 274-287
        • Terblanche J
        • Burroughs AK
        • Hobbs KEF
        Controversies in the management of bleeding esophageal varices.
        N Engl J Med. 1989; 320: 1393-1398
        • Terblanche J
        • Burroughs AK
        • Hobbs KEF
        Controversies in the management of bleeding esophageal varices.
        N Engl J Med. 1989; 320: 1469-1475
        • Henderson JM
        • Kutner MH
        • Millikan WJ
        • et al.
        Endoscopic variceal sclerosis compared with distal splenorenal shunt to prevent recurrent variceal bleeding in cirrhosis.
        Ann Intern Med. 1990; 112: 262-269
        • Teres J
        • Bordas JM
        • Bravo D
        • et al.
        Sclerotherapy vs distal splenorenal shunt in the elective treatment of variceal hemorrhage: a randomized controlled trial.
        Hepatology. 1987; 7: 430-436
        • Rikkers LF
        • Jin G
        • Burnett DA
        • Buchi KN
        • Cormier RA
        Shunt surgery versus endoscopic sclerotherapy for variceal hemorhage: late results of a randomized trial.
        Am J Surg. 1993; 165: 27-33
        • Spina GP
        • Santambrogio R
        • Opocher E
        Distal splenorenal shunt versus endoscopic sclerotherapy in the prevention of variceal bleeding: first stage of a randomized controlled trial.
        Ann Surg. 1990; 211: 178-186
        • Langer B
        • Taylor BR
        • Mackenzie DR
        • Gilas T
        • Stone RM
        • Blendis L
        Further report of a prospective randomized trial comparing distal splenorenal shunt with end-to-side portacaval shunt.
        Gastroenterology. 1985; 88: 424-429
        • Fischer JEF
        • Bower RH
        • Atamian S
        • Welling R
        Comparison of distal and proximal splenorenal shunts.
        Ann Surg. 1981; 194: 531-544
        • Lacy AM
        • Navasa M
        • Gilabert R
        • et al.
        Long-term effects of distal splenorenal shunt on hepatic hemodynamics and liver function in patients with cirrhosis: importance of reversal of portal blood flow.
        Hepatology. 1992; 15: 616-622
        • Reichle FA
        • Fahmy WF
        • Golsorkhi M
        Prospective comparative clinical trial with distal splenorenal and mesocaval shunts.
        Am J Surg. 1979; 137: 13-21
        • Lezek MD
        Neuropsychological assessment.
        Oxford University Press, New York1976
        • Alinder G
        • Herlin P
        • Holmin T
        The cost-effectiveness of early and delayed surgery in acute cholecystitis.
        World J Surg. 1985; 9: 329-334
        • Paquet K-J
        • Mercado MA
        • Kalk J-Fr
        • Koussouris P
        • Siemens F
        • Muting D
        Analysis of a prospective series of 100 mesocaval interposition shunts for bleeding portal hypertension.
        Hepatogastroenterology. 1990; 37: 115-120
        • Sarfeh IJ
        • Rypins EB
        • Conroy RM
        • Mason GR
        Portacaval H-graft: relationships of shunt diameter, portal flow patterns and encephalopathy.
        Ann Surg. 1983; 197: 422-426
        • Warren WD
        • Millikan WJ
        • Henderson MJ
        • et al.
        Selective variceal decompression after splenectomy or splenic vein thrombosis: with a note on splenopancreatic disconnection.
        Ann Surg. 1985; 199: 694-706
        • Cell JP
        • Grendell JH
        • Crass RA
        • Weber TE
        • Trunkey DD
        Endoscopic sclerotherapy versus portacaval shunt in patients with severe cirrhosis and acute variceal hemorrhage.
        N Engl J Med. 1987; 316: 11-15
        • Planas R
        • Boix J
        • Broggi M
        • et al.
        Portacaval shunt versus endoscopic sclerotherapy in the elective treatment of variceal hemorrhage.
        Gastroenterology. 1991; 100: 1078-1086
        • Zeppa R
        • Hensley GT
        • Levi JU
        • et al.
        The comparative survivals of alcoholics versus non-alcoholics after distal spleno-renal shunt.
        Ann Surg. 1978; 187: 510-514
        • Endozain Sosa JC
        • Munoz Nunez F
        • Rodriguez Blanes JA
        • et al.
        Digestive hemorrhage caused by gastric varices: usefulness of the techniques of endoscopic sclerosis.
        Rev Esp Enferm Dig. 1992; 82: 79-82